December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Do you know about professional patient navigation? – American Cancer Society
Apr 28, 2024, 11:25

Do you know about professional patient navigation? – American Cancer Society

Karen Knudsen shared a post by the American Cancer Society on LinkedIn:

“Every person diagnosed with cancer should have access to high-quality navigation across the cancer continuum.

By leveraging the American Cancer Society’s expertise in navigation to train and credential others, we’re working to expand the capacity for cancer navigation while contributing to the standardization of best practices in this critical area of care.”

Quoting American Cancer Society’s post:

“Do you know about professional patient navigation? It’s a proven way to boost cancer outcomes from screening to survivorship. With the American Cancer Society Leadership in Oncology Navigation training, we’re raising the bar and making sure everyone gets top-notch support through their entire cancer journey.

Learn more.”

Link to video.
Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.

She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR).

Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers.

She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.